These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33023653)

  • 1. Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer's disease: a retrospective cohort analysis.
    O'Connor A; Weston PSJ; Pavisic IM; Ryan NS; Collins JD; Lu K; Crutch SJ; Alexander DC; Fox NC; Oxtoby NP
    Alzheimers Res Ther; 2020 Oct; 12(1):126. PubMed ID: 33023653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study.
    Pavisic IM; Nicholas JM; Pertzov Y; O'Connor A; Liang Y; Collins JD; Lu K; Weston PSJ; Ryan NS; Husain M; Fox NC; Crutch SJ
    Neuropsychologia; 2021 Nov; 162():108028. PubMed ID: 34560142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-driven models of dominantly-inherited Alzheimer's disease progression.
    Oxtoby NP; Young AL; Cash DM; Benzinger TLS; Fagan AM; Morris JC; Bateman RJ; Fox NC; Schott JM; Alexander DC
    Brain; 2018 May; 141(5):1529-1544. PubMed ID: 29579160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
    Lin Y; Shan PY; Jiang WJ; Sheng C; Ma L
    Neurol Sci; 2019 Jan; 40(1):41-49. PubMed ID: 30397816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.
    Tam A; Laurent C; Gauthier S; Dansereau C
    J Prev Alzheimers Dis; 2022; 9(3):400-409. PubMed ID: 35841241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    Williams OA; An Y; Armstrong NM; Kitner-Triolo M; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2020; 75(4):1169-1180. PubMed ID: 32390623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [
    O'Connor A; Cash DM; Poole T; Markiewicz PJ; Fraser MR; Malone IB; Jiao J; Weston PSJ; Flores S; Hornbeck R; McDade E; Schöll M; Gordon BA; Bateman RJ; Benzinger TLS; Fox NC
    Alzheimers Res Ther; 2023 May; 15(1):99. PubMed ID: 37231491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
    Mormino EC; Papp KV; Rentz DM; Donohue MC; Amariglio R; Quiroz YT; Chhatwal J; Marshall GA; Donovan N; Jackson J; Gatchel JR; Hanseeuw BJ; Schultz AP; Aisen PS; Johnson KA; Sperling RA
    Alzheimers Dement; 2017 Sep; 13(9):1004-1012. PubMed ID: 28253478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
    Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
    Langbaum JB; Hendrix SB; Ayutyanont N; Chen K; Fleisher AS; Shah RC; Barnes LL; Bennett DA; Tariot PN; Reiman EM
    Alzheimers Dement; 2014 Nov; 10(6):666-74. PubMed ID: 24751827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
    Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
    Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
    Mazzeo S; Lassi M; Padiglioni S; Vergani AA; Moschini V; Scarpino M; Giacomucci G; Burali R; Morinelli C; Fabbiani C; Galdo G; Amato LG; Bagnoli S; Emiliani F; Ingannato A; Nacmias B; Sorbi S; Grippo A; Mazzoni A; Bessi V
    BMC Neurol; 2023 Aug; 23(1):300. PubMed ID: 37573339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.